| Report ID |
168941 |
| Drug Identification Number |
02238830 |
| Brand name |
CLAVULIN 400 |
| Common or Proper name |
amoxicillin / clavulanate potassium for oral suspension |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
AMOXICILLIN
CLAVULANIC ACID |
| Strength(s) |
400MG
57MG |
| Dosage form(s) |
POWDER FOR SUSPENSION |
| Route of administration |
ORAL
ORAL |
| Packaging size |
70ML |
| ATC code |
J01CR |
| ATC description |
BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage |
Demand increase for the drug. |
| Anticipated start date |
|
| Actual start date |
2022-09-05 |
| Estimated end date |
2023-03-31 |
| Actual end date |
2023-03-15 |
| Shortage status |
Resolved |
| Updated date |
2024-02-14 |
| Company comments |
Inventory on allocation to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
